促销时间表 Greenwich LifeSciences, Inc.
先进的时间表
简单图表
关于公司 Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.| IPO date | 2020-09-25 |
|---|---|
| ISIN | US3968791083 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://greenwichlifesciences.com |
| Цена ао | 10.63 |
| 每日价格变化: | -0% (10.71) |
|---|---|
| 每周价格变化: | -3.6% (11.11) |
| 每月价格变化: | -8.93% (11.76) |
| 3个月内价格变化: | -6.87% (11.5) |
| 六个月内的价格变化: | -25.47% (14.37) |
| 每年价格变化: | -46.29% (19.94) |
| 3年内价格变化: | -50.6% (21.68) |
| 年初以来价格变化: | -6.87% (11.5) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 机构 | 体积 | 分享, % |
|---|---|---|
| Vanguard Group Inc | 221682 | 1.73 |
| Blackrock Inc. | 57148 | 0.44 |
| Ameriprise Financial, Inc. | 53647 | 0.42 |
| Geode Capital Management, LLC | 46816 | 0.36 |
| Renaissance Technologies, LLC | 36600 | 0.28 |
| Northern Trust Corporation | 20983 | 0.16 |
| 683 Capital Management LLC | 19604 | 0.15 |
| Qube Research & Technologies Ltd | 14714 | 0.11 |
| JANE STREET GROUP, LLC | 14005 | 0.11 |
| State Street Corporation | 13002 | 0.1 |
| ETF | 分享, % | 本年盈利能力, % | 股息, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.02306 | 17.09 | 1.54048 |
| Vanguard Russell 2000 Growth ETF | 0.01 | 23.05 | 0.60264 |
iShares Russell 2000 Growth ETF
|
0.00627 | 38.04 | 0.6026 |
ProShares UltraPro Russell2000
|
0.00192 | 89.82 | 1.47873 |
| ProShares Hedge Replication ETF | 0.0005 | 5.92 | 1.47892 |
| Vanguard Russell 2000 ETF | 0 | 17.16 | 1.48801 |
| Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
| 0.01 | 31.85 | 1.23 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Mr. Snehal S. Patel | CEO, CFO & Director | 1.09M | 1964 (61 年) |
| Mr. Eric Rothe | Founder & Independent Director | 65.64k | 1976 (49 年) |
| Dr. Frank Joseph Daugherty M.D. | Chief Medical Officer & Director | N/A | 1951 (74 年) |
| Dr. Jaye L. Thompson Ph.D. | Vice President Clinical & Regulatory Affairs | N/A | 1966 (59 年) |
| Dr. Christine T. Fischette Ph.D. | VP of Business Development | N/A | 1951 (74 年) |
地址: United States, Stafford. TX, Building 14 - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://greenwichlifesciences.com
网站: https://greenwichlifesciences.com
